We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies.

... Research & Development

For us, innovation goes beyond drug development. Our innovation is built on expert knowledge of disease-pathophysiology’s, understanding of the patient, the use of big data and state-of-the-art technologies such as devices that result in innovative solutions for the patients need.

... Strategy

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates and technologies in different phases of development.

... Pipeline

Our key innovation area is pain.

... Focus area

Collaboration with the scientific community is central to our R&D strategy. Let’s work together – collaborate with us!

... Collaborate with us

We believe that success comes from close collaborations founded on a shared vision to develop innovative medicines for patients that suffer from diseases with high unmet needs.

... Partnering

We strengthen and develop our core markets Europe, North America, Latin America and Asia through acquisitions, asset deals, in-licensing, commercialization and distribution deals.

... Areas of interest

We work with the world’s biggest public-private partnership organisation in the life sciences as co-leaders of the latest pain initiative.

... Public Private Partnerships

Grünenthal – innovating to improve lives

We are skilled entrepreneurs and scientists working together to develop new solutions for patients suffering from pain-related diseases and adjacent conditions.

We combine our internal R&D capabilities with a collaborative network approach to ensure success. Patients are central in the journey towards developing effective pain solutions. Through our work with patient organisations and direct interaction with patients, we have been able to create tangible improved outcomes for patients.

Gabriel Baertschi, Chief Executive Officer

“Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies. Innovation is more than just the development of new medications. It’s about expanding our knowledge, exploring new and different treatment approaches, exploiting technologies and harnessing big data. We want to improve patients’ lives. That’s why we continually seek opportunities to innovate.”

Gabriel Baertschi

Chief Executive Officer, Grünenthal

Filling our pipeline with innovations

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates and technologies in different phases of development.

... Explore

Our focus

Pain

Tackling the unmet need with nearly 50 years of research experience

... Explore

PainSolve research community

Working together to find Solutions for pain

Share and connect with us

... Visit Pain Solve

Our passion for innovation touches all that we do

Commitment to R&D

We constantly strive for best-in-class solutions for our patients by investing in our own R&D and building global scientific networks.

Broad in-house competence

We have R&D capabilities that span from idea generation to the launch of innovative therapies.

International focus

Our innovation is truly global. Our worldwide collaborations enable patients around the world to experience the benefits of our R&D efforts and innovations.

The R&D engine

R&D enables us to meet our business goals by delivering innovative solutions to patients. Our successful track record of product launches are testament to this.

Combining forces

We are proud of our fully integrated R&D infrastructure and the capabilities we have to bring a product from early development to market. Still, there are some things we cannot do alone - so we are constantly looking for Partners to collaborate on promising new development projects.

... Explore Partnering